Product development is our core competency having Formulation Development Lab, Analytical Development Lab and Stability Chambers to cater formulation needs during Formulation development.
We will do the literature search, patent landscaping, and strategy development. Based on the formula and process optimization studies using DOE concept, final composition and manufacturing process we can be recommended the lead formulation for bio-study and scale-up.
The lead formulation will be optimized for a smooth scale up/ Pilot BE batches and process robustness & reproducibility in commercial batches.
We have domain expertise of reverse engineering tasks where we have analytical model as well as complete Q1Q2 support mechanism.
We have competency in API Sameness, Complex Characterization and API PSD Determination in FDF
Formulation development Scope
New Dosage Form Development
Generic Development
Life Cycle Extension / Brand Extension
Solubilization / Bioavailability Enhancement
Platform Technology Development
Nutraceuticals and Food Technology Development
Herbal Cosmetic Preparations for the Regulated Market
Lyophilized Products / Parenteral Dosage Form Development
Eye Care Products Development by New and Conventional Technology
Analytical development Scope
Analytical method development for non-pharmacopoeial products
Analytical method development for all dosage forms of oral solid dosage (OSD) forms, including tablets, capsules, granules, complex capsules, complex modified-release (MR) tablets, creams, ointments, injections, and depot release products
Analytical method development for non-pharmaceutical products such as nutraceutical products, herbal formulations, and food products
Method validation & Equivalency studies
Timely updates of pharmacopoeia standards
Method upgrades
Regulatory Query updates
Collaborative Project High-End Research Project
Industry-Academic Collaboration funded by DST
In collaboration with a medium scale healthcare industry, we can develop new products and processes in niche areas like Ayurceuticals and Herbaceuticals
Biosimilars & Biotechnology Products
Anticancer drugs sources: Plant derived seeds, isolation, enhancement of the active constituent, formulation and clinical trials and finally registration and commercialization.
